Ensign Peak Advisors’s Alpine Immune Sciences, Inc. Common Stock ALPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-140,043
| Closed | -$5.55M | – | 1753 |
|
|
2024
Q1 | $5.55M | Buy |
140,043
+10,068
| +8% | +$399K | 0.01% | 609 |
|
|
2023
Q4 | $2.48M | Buy |
+129,975
| New | +$2.48M | ﹤0.01% | 828 |
|
|
2022
Q2 | – | Sell |
-110,017
| Closed | -$987K | – | 2218 |
|
|
2022
Q1 | $987K | Buy |
110,017
+37,087
| +51% | +$333K | ﹤0.01% | 1214 |
|
|
2021
Q4 | $1.01M | Hold |
72,930
| – | – | ﹤0.01% | 1275 |
|
|
2021
Q3 | $778K | Buy |
72,930
+18,350
| +34% | +$196K | ﹤0.01% | 1515 |
|
|
2021
Q2 | $491K | Hold |
54,580
| – | – | ﹤0.01% | 1598 |
|
|
2021
Q1 | $579K | Buy |
54,580
+18,505
| +51% | +$196K | ﹤0.01% | 1579 |
|
|
2020
Q4 | $455K | Buy |
+36,075
| New | +$455K | ﹤0.01% | 1618 |
|